Objectif Western blot is an imperative technique in many fields of clinical and research biology, enabling protein detection which is relevant for several types of diagnosis and analyses. It presents many applications, from AIDS diagnosis to searching for new drug targets. Therefore, western blot is used by 80% of laboratories at pharmaceutical companies, clinical and research centres worldwide.After several laboratory stages, proteins are detected through image processing. In recent years, there have been attempts to automate this step, but these solutions are dependent of expensive devices to detect and digitize images, and analytical software, forcing many laboratories to choose inefficient and time-consuming manual methods.The need resulting from these barriers has been identified together with our Lead Clients, two reference laboratories in Spain and France. Within this context, ODR is the first ubiquitous solution to detect and process image results from the Western Blot protein analytic technique, by using the camera of normal smart phones or tablets finally allowing to obtain standardized results in a few minutes, and make them available to clinical and research teams worldwide. We have detected the potential functional scalability of ODR, since several analytic techniques are based on image treatment. This business opportunity has been defined as the innovation strategy of our company for the coming years, in which the collaboration with expert profiles will be crucial for its execution. This way, a full functional product will become an entry barrier for future competitors, providing a mechanism for sustainable growth. In order to achieve the objectives for develop ODR project and build commercial alliances for its future exploitation, we need to reinforce our team with a PhD on biochemistry or molecular biology familiarized with laboratory techniques for protein detection and quantification, with commercial and negotiations skills. Champ scientifique natural sciencescomputer and information sciencessoftwareengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensorsnatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccinesnatural sciencescomputer and information sciencesdata sciencedata processing Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs Thème(s) INNOSUP-02-2016 - European SME innovation Associate - pilot Appel à propositions H2020-INNOSUP-2016-2017 Voir d’autres projets de cet appel Sous appel H2020-INNOSUP-02-2016 Régime de financement CSA - Coordination and support action Coordinateur MERCARISTA SL Contribution nette de l'UE € 86 625,00 Adresse CALLE IRIS 2, PORTAL 3, PLANTA 1, PUERTA 5 28232 LAS ROZAS DE MADRID Espagne Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Comunidad de Madrid Comunidad de Madrid Madrid Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 86 625,00
